Projekttitel
SAKK Cancer oncology clinical trial
Projekttitel Englisch
A randomized phase III trial to determine the effect of consolidation with rituximab (IDEC C2B8 Mabthera) in patients with CD20+ follicular or mantle cell lymphoma having received induction therapy with rituximab weekly x 4
